Neoplasms (Tumors)
Neoplasms are abnormal growths of tissue that can be benign (non-cancerous) or malignant (cancerous). This category includes various types of tumors, cysts, and polyps that can develop in different parts of the body.
Advanced Solid Tumors: ODM-212 Study
We are testing a new oral medication, ODM-212, in patients with advanced solid tumors to evaluate its safety and how well it may work. This study aims to find the best dose and understand its effects on tumor growth.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a solid tumor that has spread or is locally advanced?
- Are you currently pregnant or breastfeeding?
- Are you taking any blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had major surgery in the past 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Odm-212
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Helsinki University Central Hospital
Oncology
Helsinki, Finland
Oulu University Hospital
Neurology
Oulu, Finland
Turku University Hospital
Oncology
Turku, Finland
Sponsor: Orion Corporation
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.